Oral colonization by Levilactobacillus brevis KABPTM-052 and Lactiplantibacillus plantarum KABPTM-051: A Randomized, Double-Blinded, Placebo-Controlled Trial (Pilot Study) | Zendy

José Nart | Zendy; S. Jiménez-Garrido | Zendy; Anaïs Ramírez-Sebastià | Zendy; Erola Astó | Zendy; David Buj | Zendy; Pol Huedo | Zendy; Jordi Espadaler | Zendy

Open Access

Oral colonization by Levilactobacillus brevis KABPTM-052 and Lactiplantibacillus plantarum KABPTM-051: A Randomized, Double-Blinded, Placebo-Controlled Trial (Pilot Study)

Author(s) -

José Nart,

S. Jiménez-Garrido,

Anaïs Ramírez-Sebastià,

Erola Astó,

David Buj,

Pol Huedo,

Jordi Espadaler

Publication year - 2021

Publication title -

journal of clinical and experimental dentistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.481

H-Index - 23

ISSN - 1989-5488

DOI - 10.4317/jced.57771

Subject(s) - placebo , probiotic , medicine , saliva , lactobacillus plantarum , gingivitis , randomized controlled trial , placebo controlled study , gastroenterology , dentistry , biology , double blind , pathology , lactic acid , alternative medicine , bacteria , genetics

To determine the oral colonization capacity of the strains Levilactobacillus brevis KABPTM-052 (CECT 7480) and Lactiplantibacillus plantarum KABPTM-051 (CECT 7481) in healthy subjects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research